Literature DB >> 20186812

Cold-induced sweating syndrome with neonatal features of Crisponi syndrome: longitudinal observation of a patient homozygous for a CRLF1 mutation.

Masanori Yamazaki1, Tomoki Kosho, Shigeo Kawachi, Maiko Mikoshiba, Jun Takahashi, Rena Sano, Kenji Oka, Kunihiro Yoshida, Tomoharu Watanabe, Hiroyuki Kato, Mitsuhisa Komatsu, Rie Kawamura, Keiko Wakui, Per M Knappskog, Helge Boman, Yoshimitsu Fukushima.   

Abstract

Cold-induced sweating syndrome (CISS) is a rare autosomal recessive disorder caused by mutations in CRLF1 (cytokine receptor-like factor 1), characterized by profuse sweating in cold environmental temperature and craniofacial and skeletal features. Mutations in CRLF1 also cause Crisponi syndrome (CS), characterized by neonatal-onset paroxysmal muscular contractions as well as craniofacial and skeletal manifestations and abnormal functions of the autonomic nerve system. To date, it is an unresolved problem whether the two conditions are distinct clinical entities or a single clinical entity with variable expressions or with different presentations depending on the patients' age at diagnosis. We report on a 30-year-old Japanese woman with CISS and homozygous out-of-frame 23-base deletion of CRLF1. In infancy, she did not show paroxysmal muscular contractions, but showed feeding difficulty, hyperthermia, and facial characteristics including thick and arched eyebrows, a short nose with anteverted nostrils, full cheeks, an inverted upper lip, and a small mouth, resembling those observed in CS. Profuse sweating was noticed at 3 years of age. Cold-induced sweating was recognized in her elementary school days. In adolescence to adulthood, she showed a Marfanoid habitus with progressive kyphoscoliosis and craniofacial characteristics including dolichocephaly, a slender face with poor expression, a distinctive nose with hypoplastic nares, malar hypoplasia, prognathism, and a small mouth. This is the first report of detailed longitudinal observation of a patient with CRLF1 abnormalities, compatible with the notion that CISS and CS may be a single clinical entity. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186812     DOI: 10.1002/ajmg.a.33315

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

Review 1.  Cytokine-like factor 1 (CLF1): life after development?

Authors:  Daniel J Kass
Journal:  Cytokine       Date:  2011-06-28       Impact factor: 3.861

2.  Differential secretion of the mutated protein is a major component affecting phenotypic severity in CRLF1-associated disorders.

Authors:  Jana Herholz; Alessandra Meloni; Mara Marongiu; Francesca Chiappe; Manila Deiana; Carmen Roche Herrero; Giuseppe Zampino; Hanan Hamamy; Yusra Zalloum; Per Erik Waaler; Giangiorgio Crisponi; Laura Crisponi; Frank Rutsch
Journal:  Eur J Hum Genet       Date:  2011-02-16       Impact factor: 4.246

3.  Role of cytokine receptor-like factor 1 in hepatic stellate cells and fibrosis.

Authors:  Lela Stefanovic; Branko Stefanovic
Journal:  World J Hepatol       Date:  2012-12-27

4.  CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.

Authors:  Shi-Tong Yu; Qian Zhong; Ren-Hui Chen; Ping Han; Shi-Bing Li; Hua Zhang; Li Yuan; Tian-Liang Xia; Mu-Sheng Zeng; Xiao-Ming Huang
Journal:  Cell Death Dis       Date:  2018-03-07       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.